ALGN

Nasdaq

ALIGN TECHNOLOGY INC

Health Care, Health Care Supplies

$173.66

close 7 Aug 2026

+28.81%

52-week change

$12.37B

market cap

$122.00

$200.44

52-week range

Expected price

$193.49 – $236.49

Current price

$173.66

Signal

Could be undervalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)30.25x

P/S (TTM)2.99x

P/B2.92x

EV/EBITDA (TTM)—

FCF yield (TTM)5.12%

PEG (TTM, GAAP)4.31

Context

P/E, own 5-year average43.98x

P/E, sector median29.65x*

Price at 5-year median P/E$219.29*

Forward — analyst consensus

Forward P/E (FY2026)15.38x*

Forward P/E (FY2027)13.84x

Forward PEG1.38*

Consensus EPS FY2026 (17 analysts)$11.29

EPS growth (FY2026→FY2027)11.13%

Revenue growth (FY2026)3.26%

Street view

Price target (mean)$208.60*

Target upside20.12%

Ratings (buy / hold / sell)10 / 6 / 1

FY2026 EPS revisions, 30d (up / down)1 / 2

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR -0.66%10Y CAGR +10.28%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$173.66

Cash & equivalents$1.10B

Total debt—

Shares outstanding71.25M

Result

DCF price per share—

Current price$173.66

Margin of safety—

PV of years 1–10$4.12B

PV of terminal value$5.12B

Equity value—

Market-implied growth—

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$629.39M	$625.23M	$621.11M	$617.01M	$612.94M	$608.89M	$604.87M	$600.88M	$596.91M	$592.97M	$11.05B
PV	$582.77M	$536.04M	$493.06M	$453.52M	$417.15M	$383.70M	$352.94M	$324.64M	$298.61M	$274.66M	$5.12B

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026